Meliane

Ethinylestradiol, the active ingredient in Meliane, is a combined oral contraceptive presented as a tablet for oral use. It is used to prevent pregnancy in women of reproductive age by regulating hormonal cycles. GNH USA supplies Meliane as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Meliane, a combined oral contraceptive, is used to prevent pregnancy by modulating the hormonal axis.

Contraception: prevents ovulation and pregnancy when taken as prescribed. Acne treatment: reduces androgen‑driven skin lesions in women. Dysmenorrhea management: alleviates painful menstrual cramps and regulates bleeding patterns.

Common Side Effects: - Nausea or upset stomach - Breast tenderness or enlargement - Headache or migraine - Weight gain or fluid retention - Mood changes or irritability - Breakthrough or spotting bleeding

Serious or Rare Side Effects: - Venous thromboembolism (deep‑vein thrombosis, pulmonary embolism) - Arterial thrombosis (stroke, myocardial infarction) - Severe hypertension or hypertensive crisis - Liver adenoma or benign hepatic tumor - Gallbladder disease (cholestasis, gallstones) - Anaphylaxis or severe allergic reaction

Before initiating therapy, consider individual risk factors and contraindications. - Thrombotic risk assessment: evaluate personal or family history of clotting disorders. - Smoking restriction: avoid use in women who smoke more than 15 cigarettes per day. - Liver disease review: contraindicated in active or severe hepatic impairment. - Blood pressure monitoring: check for hypertension before and during treatment. - Missed pill guidance: provide clear instructions on how to manage missed doses. - Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Major Interactions (Avoid): - Enzyme inducers (e.g., rifampin, carbamazepine): reduce contraceptive effectiveness. - Antiretroviral efavirenz: may lower hormone levels and increase pregnancy risk. - St. John’s wort: accelerates metabolism of estrogen and progestin components. - Certain antifungals (e.g., griseofulvin): decrease plasma concentrations of active ingredients. - Anticonvulsants (e.g., phenobarbital): may compromise contraceptive reliability.

Moderate Interactions (Monitor Closely): - SSRIs (e.g., fluoxetine): may increase risk of bleeding or affect hormone levels. - Antihypertensives (e.g., ACE inhibitors): monitor blood pressure for additive effects. - Diuretics: may alter electrolyte balance when combined with hormonal therapy. - Herbal supplements (e.g., ginkgo biloba): potential for increased bleeding risk. - Antibiotics (e.g., tetracycline): generally minimal effect but advise vigilance.